Preliminary experience of fractionated stereotactic radiosurgery with extend system of Gamma Knife
Purpose: The purpose of this study is to present multisession stereotactic radiosurgery with initial experience using custom made extend system (ES) of Gamma Knife.
Methods: The ES is comprised of a carbon fiber frame also called extend frame, vacuum head rest cushion, patient surveillance unit and a configurable front piece with dental impression tray. The extend frame is a rigid connection between patient's head and patient positioning system (PPS) of Gamma Knife. A dental impression of patient was created and attached to the frontal piece of extend system. The treatment setup involves positioning the patient within the extend frame using patient specific headrest cushion and front piece. The reference patient’s head position was recorded through measurements of repositioning check tool (RCT) apertures using a high precision digital probe before computed tomography (CT) scan. The RCT measurements taken before treatment were compared with recorded reference position to ensure appropriate patient treatment position. Volumetric magnetic resonance (MR) scan was co-registered with stereotactic CT scan on Leksell Gamma plan. Fused MR to CT images on Gamma Plan was utilized to delineate regions of interest and prepare a precise treatment plan. The presented study includes positional reproducibility check and dosimetric evaluation of ten patients treated with ES.
Results: Forty-three fractions on ten patients with prescribed treatment format were delivered successfully. An average tumor volume of 11.26 cm3 (range, 340 mm3 to 59.12 cm3) was treated with ES. The mean tumor coverage of 91.91% (range, 90% to 95%) was able to achieve at 50% prescription isodose without compromising adjacent normal structure radiation dose tolerances. The mean inter-fraction positional variation of 0.69 mm influences an inherent strength of immobilization technique. Follow-up of seven patients at a median interval of 16 months (range, 9 months to 26 months) showed evidence of 100% radiographic control with improved clinical results.
Conclusion: Conjugative clinical outcome shows the efficacy of fractionation in various clinical indications.
Firlik AD, Levy EI, Kondziolka D, et al. Staged volume radiosurgery followed by microsurgical resection: a novel treatment for giant cerebral arteriovenous malformations: technical case report. Neurosurgery. 1998;43:1223-8.
Haselsberger K, Maier T, Dominikus K et al. Staged gamma knife radiosurgery for large critically located benign meningiomas: evaluation of a series comprising 20 patients. J Neurol Neurosurg Psychiatry. 2009;80:1172-5.
Iwai Y, Yamanaka K, Nakajima H. Two-staged gamma knife radiosurgery for the treatment of large petroclival and cavernous sinus meningiomas. Surg Neurol. 2001;56:308-14.
Javalkar V, Pillai P, Vannemreddy P, et al. Gamma knife radiosurgery for arteriovenous malformations located in eloquent regions of the brain. Neurol India. 2009;57:617-21.
Kim JW, Im YS, Nam DH, et al. Preliminary report of multisession gamma knife radiosurgery for benign perioptic lesions: visual outcome in 22 patients. J Korean Neurosurg Soc. 2008;44:67- 71.
Niranjan A, Gobbel GT, Kondziolka D, et al. Experimental radiobiological investigations into radiosurgery: present understanding and future directions. Neurosurgery. 2004;55:495- 504.
Adler JR, Gibbs IC, Puataweepong P, et al. Visual field preservation after multisession cyberknife radiosurgery for perioptic lesions. Neurosurgery. 2008;62(Suppl 2):733-43.
Tuniz F, Soltys SG, Choi CY et al. Multisession Cyberknife stereotactic radiosurgery of large, benign cranial base tumors: preliminary study. Neurosurgery. 2009; 65: 898-907.
Milker-Zabel S, Huber P, Schlegel W, et al. Fractionated stereotactic radiation therapy in the management of primary optic nerve sheath meningiomas. J Neurooncol. 2009;94:419-24.
Simonova G, Novotny J, Novotny J Jr, et al. Fractionated stereotactic radiotherapy with the Leksell Gamma Knife: feasibility study. Radiother Oncol. 1995;37:108-16.
Sayer FT, Sherman JH, Yen CP, et al. Initial experience with the extend system: A relocatable frame system for multiple-session gamma knife radiosurgery. World Neurosurg. 2011;75(5-6):665-72.
Wells WM 3rd, Viola P, Atsumi H, et al. Multi-modal volume registration by maximization of mutual information. Med Image Anal. 1996;1(1):35-51.
Elia AE, Shih HA, Loeffler JS. Stereotactic radiation treatment for benign meningiomas. Neurosurg Focus. 2007;23(4):E5.
Killory BD, Kresl JJ, Wait SD, et al. Hypofractionated cyberknife radiosurgery for perichiasmatic pituitary adenomas: early results. Neurosurgery. 2009;64:A19-25.
Milker-Zabel S, Zabel-du Bois A, Huber P, et al. Fractionated stereotactic radiation therapy in the management of benign cavernous sinus meningiomas: long-term experience and review of the literature. Strahlenther Onkol. 2006; 182:635-40.
Park C, Papiez L, Zhang S, et al. Universal survival curve and single fraction equivalent dose: useful tools in understanding potency of ablative radiotherapy. Int J Radiat Oncol Biol Phys. 2008;70:847-52.
Devriendt D, De Smedt F, Glineur R, Massager N. Five-fraction gamma knife radiosurgery using the extend relocatable system for benign neoplasms close to optic pathways. Pract Radiat Oncol. 2015;5(3):119-25.
Ruschin M, Nayebi N, Carlsson P, et al. Performance of a novel repositioning head frame for Gamma Knife Perfexion and image-guided linac-based intracranial stereotactic radiotherapy. Int J Radiat Oncol Biol Phys. 2010;78:306-13.
Schlesinger D, Xu Z, Taylor F, et al. Interfraction and intrafraction performance of the gamma knife extend system for patient positioning and immobilization. J Neurosurg. 2012;117 suppl: 217-24.
Ma L, Pinnaduwage D, McDermotte M, Sneed PK. Whole-procedural radiological accuracy for delivering multi-session gamma knife radiosurgery with a relocatable frame system. Technol Cancer Res Treat. 2014;13(5)403-8.
This work is licensed under a Creative Commons Attribution 3.0 License.
International Journal of Cancer Therapy and Oncology (ISSN 2330-4049)
© International Journal of Cancer Therapy and Oncology (IJCTO)
To make sure that you can receive messages from us, please add the 'ijcto.org' domain to your e-mail 'safe list'. If you do not receive e-mail in your 'inbox', check your 'bulk mail' or 'junk mail' folders.